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Available online 30 September 2014Abstract The Disposable Soma Theory holds that genetic integrity will be maintained at more pristine levels in germ cells
than in somatic cells because of the unique role germ cells play in perpetuating the species. We tested the hypothesis that the
same concept applies to pluripotent cells compared to differentiated cells. Analyses of transcriptome and cistrome databases,
along with canonical pathway analysis and chromatin immunoprecipitation confirmed differential expression of DNA repair and
cell death genes in embryonic stem cells and induced pluripotent stem cells relative to fibroblasts, and predicted extensive
direct and indirect interactions between the pluripotency and genetic integrity gene networks in pluripotent cells. These data
suggest that enhanced maintenance of genetic integrity is fundamentally linked to the epigenetic state of pluripotency at the
genomic level. In addition, these findings demonstrate how a small number of key pluripotency factors can regulate large
numbers of downstream genes in a pathway-specific manner.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The “Disposable Soma Theory,” first described in 1977 by
Kirkwood (1977) implies that because germ cells are respon-
sible for conveying genetic information between generations,
and, in so doing, maintaining the species, it is evolutionarily
advantageous for these cells to expend additional energy to
maintain the integrity of their genomes at more pristine levels
than those in somatic cells. This theory has since been
validated by a variety of studies demonstrating that germ
cells maintain lower frequencies of mutations (Murphey et al.,⁎ Corresponding author at: 1 UTSA Circle, Department of Biology,
San Antonio, TX 78249, USA.
E-mail address: john.mccarrey@utsa.edu (J.R. McCarrey).
http://dx.doi.org/10.1016/j.scr.2014.09.006
1873-5061/© 2014 The Authors. Published by Elsevier B.V. This is an ope
(http://creativecommons.org/licenses/by-nc-nd/4.0/).2013; Russell et al., 1979; Russell, 2004; Walter et al., 1998),
and express elevated levels of DNA repair and/or cell death
activities relative to somatic cells (Coucouvanis et al., 1993;
Huamani et al., 2004; Intano et al., 2001, 2002; Xu et al.,
2005, 2008).
A similar argument can be posited for early embryonic
cells, which give rise to entire new individuals. Available
data support this contention, although this data is limited
because of the difficulty in recovering sufficient numbers of
pluripotent cells from early embryos to facilitate direct
analyses of mutation frequencies (Murphey et al., 2009,
2013; Russell et al., 1979; Russell, 2004; Walter et al.,
1998). Embryonic stem cells (ESCs) and induced pluripotent
stem cells (iPSCs) provide a surrogate for early embryonic
cells, and have the advantage that they can be expanded in
culture while maintaining their pluripotent status (Bradley
et al., 2012; Coucouvanis et al., 1993; Huamani et al., 2004;n access article under the CC BY-NC-ND license
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2008).
Similar to germ cells, ESCs have been shown to carry a
lower load of point mutations than that detected in
differentiated cells (Cervantes et al., 2002; Momcilović et
al., 2010). This lower load of point mutations during
expansion in culture is likely due to increased activity of
DNA repair mechanisms, which prospectively mitigate these
mutations, as additional studies have shown that expression
of DNA repair and cell death genes is generally elevated in
pluripotent stem cells relative to differentiated cell types
(Borgdorff et al., 2006; Duval et al., 2005; Fan et al., 2011;
Maynard et al., 2008; Nouspikel and Hanawalt, 2000; Tichy,
2011; Tichy and Stambrook, 2008). Several of the same DNA
repair pathways are reported to be elevated in germ cells
and pluripotent stem cells, including base excision and
mismatch repair (Intano et al., 2001; Kirkwood, 1977; Tichy
et al., 2011; Tichy and Stambrook, 2008; Tomé et al., 2013),
nucleotide excision repair (de Waard et al., 2008; Russell et
al., 1998, 2007; Tichy and Stambrook, 2008; Van Sloun et
al., 1999; Walter et al., 1998), UV and gamma radiation-
induced damage repair (Momcilović et al., 2009; Van Sloun
et al., 1999; Xu et al., 2008, 2012), homologous recombi-
nation and non-homologous end joining repair (Adams et
al., 2010a,2010b; Fan et al., 2011; Momcilović et al., 2010;
Tomé et al., 2013). Elevated cell death activity has also
been observed in ESCs, particularly that related to activity
of p53 (Li et al., 2012; Momcilović et al., 2011; Qin et al.,
2007; Roos et al., 2007). This is likely to retroactively,
rather than prospectively, mitigate the higher incidence of
large scale aberrations observed in ESCs (Ben-David and
Benvenisty, 2012; Ben-David et al., 2011; Draper et al.,
2003; Liu et al., 2013).
Germ and somatic cells, or pluripotent and differenti-
ated cells can be distinguished on the basis of their
epigenetic states (Boland et al., 2009; Okita et al., 2007;
Takahashi and Yamanaka, 2006; Yamanaka, 2012). We
previously demonstrated that epigenetic reprogramming
following somatic cell nuclear transfer results in enhanced
genetic integrity in early embryonic cells (Murphey et al.,
2009), confirming that maintenance of enhanced genetic
integrity in these cells is regulated, at least in part, by
epigenetic mechanisms.
Taken together, these observations suggest that en-
hanced genetic integrity is maintained in pluripotent cells
via elevated expression of DNA repair and/or cell death
genes coordinated by at least some of the same mechanisms
that regulate pluripotency. To test this hypothesis, we
performed a meta-analysis of transcriptome databases
describing gene expression patterns in mouse and human
ESCs and iPSCs compared to those in differentiated somatic
cells (fibroblasts). We then examined cistrome databases
describing direct or indirect regulation of these differen-
tially expressed genetic integrity genes by pluripotency
factors, or by other transcription factors which are, them-
selves, regulated by pluripotency factors. Our data confirm
extensive differential expression of genetic integrity genes
in pluripotent cell types relative to differentiated cells
(fibroblasts), and predict comprehensive interactions be-
tween the pluripotency and genetic integrity gene networks
that mechanistically link these functions at the genomic
level.Materials & methods
Transcriptome data mining
Data acquisition from GEO
Fig. 1 depicts a flow chart of data analysis procedures used
throughout this study. The Gene Expression Omnibus (GEO;
http://www.ncbi.nlm.nih.gov/geo/) was used to access raw
gene expression data for human and mouse ESCs, iPSCs, and
fibroblasts (human dermal fibroblasts [HDFs] for comparison
with human ESCs and iPSCs, and mouse embryonic fibroblasts
[MEFs] for comparison with mouse ESCs and iPSCs, respective-
ly) including mouse transcriptome datasets from GSE15267
(Chen et al., 2010), GSE13190 (Feng et al., 2009), GSE19023
(Heng et al., 2010), GSE18286 (Ichida et al., 2009), GSE17004
(Kang et al., 2009), GSE7815 (Maherali et al., 2007), GSE7841
(Okita et al., 2007), GSE14012 (Sridharan et al., 2009),
GSE5259 (Takahashi and Yamanaka, 2006), and GSE16925
(Zhao et al., 2009), all of which were derived from a minimum
of two biological replicates. Human transcriptome datasets
without replicates were from GSE12583 (Aasen et al., 2008),
GSE16654 (Chin et al., 2009), GSE9832 (Park et al., 2008),
GSE14711 (Soldner et al., 2009), and GSE9561 (Takahashi et
al., 2007). Human transcriptome datasets with biological
replicates used in this study were those from GSE25970 (Bock
et al., 2011), the super series of GSE26451 and GSE26453
(Munoz et al., 2011), GSE13828 (Ebert et al., 2008), GSE9865
(Lowry et al., 2008), GSE12390 (Maherali et al., 2008),
GSE14982 (Sun et al., 2009), and GSE15148 (Yu et al., 2009).
GenSpring GX data processing
Transcriptome data from GEO were imported into
GeneSpring GX 12.0 software and normalized individually
using default/recommended methods as described (Roy
Choudhury et al., 2010). Probe signals for cell replicates
were averaged within the software. Probes with signal
intensities less than 50.0 arbitrary fluorescence units were
excluded. A one-way ANOVA with a corrected p-value cutoff
of 0.05 using a Benjamini and Hochberg false discovery rate
multiple testing correction and Tukey's honestly significant
difference test were used to identify probes with significant
differential expression (Roy Choudhury et al., 2010). Gene
expression differences were validated by statistical signifi-
cance, and designated as differentially expressed when the
fold-change was ≥1.5×.
Probe conversion and data mining
Genetic integrity and transcription factor gene lists were
obtained from AmiGO (http://www.geneontology.org/) using
the primary gene ontology annotation terms GO:0006281
(repair), GO:0008219 (cell death), and GO:0005667 (tran-
scription factors). The function of each individual gene was
confirmed by independent literature analysis. Gene symbols
were imported into the Database for Annotation, Visualiza-
tion, and Integrated Discovery (DAVID) (Huang et al., 2008) for
conversion to array probe IDs and Entrez IDs. Probe IDs
were then imported into Mathematica (Wolfram Research,
http://www.wolfram.com/) and matches to converted gene
lists were extracted from normalized dataset files. For Entrez
IDs matched to multiple probes, average fold changes were
calculated in Microsoft Excel.
Figure 1 Pipeline for bioinformatic analysis of gene expression arrays based on filters applied. Filter A = normalization of raw data
within GeneSpring (Agilent) by Robust Multi-Array analysis (RMA); filter B = identification of probes expressedwith a raw intensity of≥50
units; filter C = two-way ANOVA with Benjamini and Hochberg correction and minimum 1.5 fold change cutoff to identify differentially
expressed probes in pairwise comparisons; filter D = literature-based confirmation of probes related to DNA repair and/or cell death;
filter E = conversion of probes to Entrez IDs using the Database for Annotation, Visualization, and Integrated Discovery (DAVID); filter F =
identification of genes differentially expressed in≥50% of examined datasets; filter G = secondary analyses of consensus lists, including
analysis with ingenuity pathway analysis (IPA) software, factor binding analysis, and matching to additional datasets.
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A consensus list of genes differentially expressed in each
pairwise comparison of cell types was made up of those IDs
found to be differentially expressed in ≥50% of datasets
examined (Supplementary Table 1).
Pathway and function analysis of differentially
expressed genes
Ingenuity pathway analysis (IPA; ingenuity systems) software
Entrez IDs and average fold change data were imported into
IPA software. DNA repair gene expression data was analyzed
for mismatch repair, nucleotide excision repair, and double
strand break repair by homologous recombination and
non-homologous end joining pathways, and cell death gene
expression data was analyzed for apoptosis, anoikis, and
autophagy. Three data points were derived for each
analysis: 1) a p-value describing the relationship of each
gene list to each pathway, 2) a ratio of differentially
expressed genes (from Supplementary Table 1) to total
genes within each pathway, and 3) a z-score representing
overall up- or down-regulation of each individual pathway.
Analysis of interactions between pluripotency and
genetic integrity gene networks
First-degree interactions
Lists of genetic integrity genes directly bound by the
pluripotency factors SOX2, OCT4, and/or NANOG in bothhuman (Boyer et al., 2005) and mouse (Chen et al., 2008; Kim
et al., 2008; Mathur et al., 2008; Sridharan et al., 2009)
pluripotent cell types were accessed and subjected to the
same list matching and extraction procedures in Mathematica
as those described above for use inmining transcriptome data.
For human ESCs and iPSCs, the lists of bound genetic integrity
genes were derived from the single available dataset (Boyer et
al., 2005), whereas for mouse ESCs and iPSCs, the lists
represent those genes reported to be bound by one or more
of the three pluripotency factors in two or more of the four
cistrome datasets examined. Direct interactions between
target genetic integrity genes or gene products and one or
more of the three pluripotency factors examinedwere termed
“first-degree interactions.”
Second-degree interactions
Human and mouse ESC and iPSC transcriptome databases
were mined in the same way we analyzed differential
expression of genetic integrity genes as described above.
Cistrome databases for these same cell types were mined to
identify transcription factor genes or gene products that
directly interact with one or more pluripotency factors
(OCT4, SOX2, or NANOG) and were differentially expressed
between pluripotent and differentiated cell types (Supple-
mentary Table 1). The pathway builder functionalities within
IPA were used to identify which of the genetic integrity genes
or gene products that are differentially expressed in human or
mouse pluripotent cells are regulated by one or more
transcription factors encoded by genes that are also a)
differentially expressed in these cell types, and b) regulated
Figure 2 Differential expression of genetic integrity genes in
mouse and human pluripotent cells. (A), DNA repair gene
expression and (B), cell death gene expression. Percentages of
genes down-regulated (green), unchanged (blue), up-regulated
(red) or not expressed (gray) are shown for each pairwise cell
type comparison (ES cells vs fibroblasts, iPS cells vs fibroblasts,
and ES cells vs iPS cells) in each species (mouse, human).
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These were termed “second-degree interactions” between
the pluripotency and genetic integrity gene networks.
Pluripotency factor knockdown functional analyses
Transcriptome datasets from mouse ESCs following shRNA
knockdowns of the pluripotency factors SOX2, OCT4, or
NANOG (Ivanova et al., 2006) were mined for differential
expression of genetic integrity genes as a function of
reduced expression of each pluripotency factor. The tran-
scriptome data were originally published as individual
datasets describing the effects of a knockdown of each
individual pluripotency factor. These three individual
datasets were combined into a single, comprehensive set
which was then mined for effects on expression of the
genetic integrity genes that we found to be a) differentially
expressed in pluripotent cells compared to differentiated
cells and b) regulated directly (first-degree interaction) by
the pluripotency gene network.
Experimental validation of computationally predicted
interactions
Chromatin immunoprecipitation (ChIP) assays were used to
validate exemplary predicted protein–DNA interactions.
ESCs from C57Bl6/J mice were propagated on γ-irradiated
CF-1 MEFs (Global Stem, Rockville, MD) in media consisting
of 82% DMEM (Life Technologies, Carlsbad, CA), 7% heat
inactivated FBS (Life Technologies), 7% ES Cult FBS (Stem
Cell Technologies, Vancouver, BC), 1% penn–strep, 1%
NEAA, and 1% Glutamax (all from Life Technologies), plus
0.0006% β-mercaptoethanol (Sigma-Aldrich), and 3 ng/mL
leukemia inhibitory factor (Stem Cell Technologies) in
six-well culture plates (Corning, Corning, NY) treated with
0.01% gelatin (Life Technologies). Cells were isolated with
0.25% trypsin (Life Technologies) and purified by MACS using
SSEA-1 antibody microbeads (Miltenyi Biotec, Bergisch
Gladbach, Germany) on an autoMACS Pro Separator
(Miltenyi Biotec) according to the manufacturer's
instructions.
ChIP was performed on purified pluripotent cells
using a combination of two kits (Active Motif, Carls-
bad, CA and AbCam, Cambridge, England) following
the manufacturer's instructions. Briefly, cells were
cross-linked with 1% formaldehyde, lysed with sodium
dodecyl sulfate [1% SDS, 50 mM Tris–HCl (pH 8.1)] and
10 nM EDTA (pH 8.0) containing protease inhibitor
cocktail (Sigma-Aldrich, St. Louis, MO) and the DNA
was sheared using a Branson Digital Sonifier as
described (Yoshioka et al., 2007). Chromatin was
immunoprecipitated using antibodies against OCT4,
SOX2, NANOG (AbCam), or phosphorylated (ser-15)
p53 (Cell Signalling Technology, Beverly, MA). Antibod-
ies against rabbit IgG (AbCam) and histone H3 were
used as negative and positive binding controls,
respectively.
qPCR was carried out using SYBR premix EX Taq (Takara
Bio, Otsu, Shiga, Japan) and a Chromo4 Real-Time System
(Bio-Rad, Berkeley, CA) with primers listed in Supplementary
Table 2. Fold enrichment calculations were based oncomparisons of bound fractions to IgG isotype controls from
at least three independent ChIP experiments and three qPCR
experiments, with the value for IgG arbitrarily set to 1.0.
Three biological replicates, each with three technical repli-
cates were performed for ChIP–qPCR reactions.
Promoter sequences (2 kb upstream of the transcriptional
start site) for ten genes were analyzed using TransFac
software (http://www.gene-regulation.com/pub/databases.
html) to identify putative binding sites for SOX2, NANOG,
OCT4, and/or p53. Primers were designed using NCBI Primer
Blast (http://www.ncbi.nlm.nih.gov/tools/primer-blast/) to
amplify fragments spanning these putative binding sites
(Supplementary Table 2).Results
Genetic integrity genes are differentially expressed
in pluripotent cells relative to differentiated cells
Our analysis of human and mouse cell gene expression
datasets is shown in Fig. 2 and Supplementary Fig. 1. We
found substantial differential expression of both DNA
repair genes and cell death genes in both human and
mouse pluripotent cells compared to differentiated cells
Figure 3 First-degree interactions between pluripotency and
genetic integrity gene networks in human ES cells. Direct
interactions between pluripotency factors and the DNA repair
or cell death gene network in human ES cells are shown. (A),
DNA repair-pluripotency network interactions and (B), cell
death-pluripotency network interactions. Red coloring indicates
up-regulation in the pluripotent cell type compared to fibro-
blast controls and green indicates down-regulation (darker
colors indicate greater expression differentials). Shapes differ-
entiate molecule types: ovals = transcription factors, dia-
monds = enzymes.
512 D.J. Cooper et al.(fibroblasts) in each species (Figs. 2A, B). Expression of N90%
of the DNA repair genes and ≥80% of the cell death genes
represented on the human and mouse microarrays examined
was detected in each pluripotent cell type. We grouped
expressed genes into three categories — 1) up-regulated
(≥1.5× and significantly different by ANOVA), 2) no
difference (i.e. b1.5× different), or 3) down-regulated
(≥1.5× and significantly different by ANOVA) in pluripotent
cells compared to differentiated cells. DNA repair gene
expression showed overall up- or similar regulation in
pluripotent cells relative to differentiated cells, with 41–
43% genes up-regulated, 44–48% genes expressed at similarlevels, and only 0.7–13% genes down-regulated (Fig. 2A).
Human and mouse ESCs and iPSCs showed substantial overall
similarity in expression of DNA repair genes (Fig. 2A), and
these minor differences likely reflect slight differences in
the pluripotent state of these cells from each species (i.e.
the naïve state in mouse pluripotent cells versus the primed
state in human pluripotent cells) (Hassani et al., 2014).
Overall, 93.8–95.1% of DNA repair genes represented on the
microarrays were expressed in pluripotent cells, indicating
that both the level and breadth of DNA repair gene
expression are high in these cells.
Cell death genes also showed substantial differential
expression in pluripotent cells compared to fibroblasts
(Fig. 2B). However, in addition to 26–47% of cell death genes
showing similar expression, approximately equal proportions
of differentially expressed cell death genes were up-(12–23%)
or down-(14–24%) regulated, respectively, in pluripotent cells
relative to differentiated cells. Complete lists of consensus
differentially expressed DNA repair and cell death genes are
shown in Supplementary Table 1. Note that in each of the
transcriptome databases we mined, fibroblasts were the only
differentiated cell type examined.
Multiple DNA repair and cell death pathways are
differentially expressed in pluripotent cells relative
to differentiated cells
We used IPA analysis to examine differential expression of
particular DNA repair or cell death pathways. We found that
most DNA repair pathways, including mismatch repair (MMR),
double-strand break repair by homologous recombination
(DSBR-HR) and double-strand break repair by non-homologous
end joining (DSBR-NHEJ), showed up-regulated expression in
pluripotent cells (as defined by more genes from the relevant
pathway being up-regulated than down-regulated in pluripo-
tent cells) (Supplementary Table 3, p = 3.98E−28–2.88E−9).
Nucleotide excision repair (NER) was the only DNA repair
pathway for which the proportion of down-regulated genes
slightly exceeded that of the up-regulated genes in pluripotent
cells (Supplementary Table 3). Although it is not listed as a
canonical pathway within IPA, we also examined expression of
genes involved in base excision repair (BER) (Friedberg et al.,
2006). Human and mouse pluripotent cells showed 35–47% of
BER genes up-regulated and 0–6% down-regulated relative to
differentiated cells (≥1.5× and significantly different by
ANOVA). Therefore this DNA repair pathway also appears to
be up-regulated in pluripotent cells. Genes associated with
apoptosis were approximately equally divided into those up- or
down-regulated in pluripotent cells (Supplementary Table 1).
However, genes associated with intrinsically activated pro-
apoptosis were particularly up-regulated in pluripotent cells,
with 85% of activators of intrinsic apoptosis being up-regulated
and 67% of inhibitors of intrinsic apoptosis being down-
regulated in these cells.
Interactions between the pluripotency and genetic
integrity gene networks
To test the hypothesis that the differential expression of
DNA repair and cell death genes in pluripotent cells
relative to differentiated cells is based on a mechanistic
513Pluripotency and Genetic Integritylink between the genetic integrity and pluripotency
gene networks, we first investigated which differentially
expressed genetic integrity genes are bound directly by one
or more of the three key pluripotency factors, OCT4, SOX2
or NANOG (“first-degree” interactions). We mined pub-
lished cistrome datasets from five studies examining
binding of pluripotency factors genome-wide, including
four datasets describing mouse pluripotent (ES and/or iPS)
cells (Chen et al., 2008; Kim et al., 2008; Mathur et al.,
2008; Sridharan et al., 2009) and one dataset describing
human pluripotent (ES) cells (Boyer et al., 2005) (Supple-
mentary Table 4). Overall, we found that 14–25% of DNA
repair genes differentially expressed in pluripotent cells are
bound by one or more of the three key pluripotency factors
examined (22% in mouse ESCs, 25% in mouse iPSCs, 15% in
human ESCs, and 14% in human iPSCs). Similarly we found
15–27% of differentially expressed cell death genes bound
by these same pluripotency factors in the same cell types
(26% in mouse ESCs, 27% in mouse iPSCs, 15% in human ESCs,
and 15% in human iPSCs). We used the IPA pathway builder
tool to visualize direct protein–DNA and protein–protein
interactions between the pluripotency and genetic integrity
networks (DNA repair and cell death). Examples of these
interactions in human embryonic stem cells are shown in
Fig. 3, while interactions in human iPSCs and mouse ESCs
and iPSCs are shown in Supplementary Fig. 2. Arrows leading
from pluripotency factors to genetic integrity genes
indicate protein–DNA interactions, while blunt connection
lines indicate protein–protein interactions.
We next investigated indirect, “second-degree” inter-
actions between the pluripotency and genetic integrity
gene networks involving intermediary factors that are,
themselves, regulated by upstream pluripotency factors
and that subsequently regulate one or more downstream
genetic integrity genes. We revisited the transcriptome
databases to identify genes encoding transcription factors
(other than the key pluripotency factors) that are differ-
entially expressed in pluripotent cells relative to differen-
tiated cells (Fig. 4). This revealed that 12–21% of theseFigure 4 Differential expression of transcription factor genes
differentiated cells. Color/comparison scheme and abbreviations artranscription factor genes are up-regulated and 13–21%
are down-regulated in pluripotent cells compared to
differentiated cells (≥1.5× and significantly different by
ANOVA).
The differentially expressed transcription factor genes
were then imported into IPA to determine which of these
genes or gene products are regulated by one or more of the
core pluripotency factors (OCT4, SOX2 and NANOG), and
which of these regulated transcription factors are, in turn,
bound to one or more differentially expressed downstream
DNA repair and/or cell death gene(s) in pluripotent cells.
Complete lists of individual DNA repair and cell death
genes bound by intermediary factors in each cell type are
provided in Supplementary Table 5 and example visual
representations of these second-degree interactions in
human ESCs are shown in Fig. 5. Representations of similar
second-degree interactions linking the pluripotency and
cell death gene networks in human iPSCs and mouse ESCs
and iPSCs are shown in Supplementary Figs. 3–5. Inclusion
of these second-degree interactions substantially expands
the extent of interactions we detected between the
pluripotency and genetic integrity gene networks in
pluripotent cells. Taken together, first- plus
second-degree interactions account for potential direct
or indirect regulation by the three pluripotency factors
investigated of 21–35% of cell death genes or gene
products and 22–50% of DNA repair genes or gene products
differentially expressed in pluripotent cell types relative
to differentiated cells.Validation of network interactions by ChIP–qPCR
We used ChIP–qPCR to validate exemplary binding interactions
between OCT4, SOX2, NANOG, and/or p53 with either
downstream genetic integrity genes or downstream transcrip-
tion factor genes inmouse ESCs. This allowed us to validate a set
of predicted first-degree interactions between pluripotency
factors and genetic integrity genes (OCT4 with Bid, Dido andin mouse and human pluripotent cell types compared to
e as described for Fig. 2.
Figure 5 Second-degree interactions between pluripotency and genetic integrity gene networks in human ES cells. Indirect
interactions between pluripotency factors and the DNA repair (A) and cell death (B) gene networks in human ES cells are shown.
Pluripotency factors are listed on the left, intermediary regulatory factors are listed in the middle, and downstream genetic integrity
genes are listed on the right in each case. Color and shape representation scheme is identical to that described in Fig. 3. Additionally,
squares = growth factors.
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Dido, Rad51 and Ercc1), plus two predicted second-degree
interactions (upstream binding of OCT4 to p53 and NANOG to
e2f1, plus downstream binding of p53 to Mlh1 and Rfc3), and acombination of first- and second-degree interactions regulating
Msh2 and Birc2 (SOX2 with Msh2 and Birc2, NANOG with Msh2
and Birc2, OCT4 with Birc2, and p53 withMsh2 and Birc2). ChIP
results are shown in Fig. 6.
Figure 6 ChIP–qPCR validation of first- and second-degree regulation of genetic integrity genes by direct or indirect interactions
with the pluripotency gene network. Exemplary ChIP–qPCR validations are shown for: i) genetic integrity genes regulated by
first-degree interactions, ii) intermediary transcription factors regulated by pluripotency factors, iii) genetic integrity genes
regulated by second-degree interactions, and iv) genetic integrity genes regulated by both first- and second-degree interactions.
Binding to the Pgk2 GC-box served as a negative control for non-specific binding. Boxes under gene graphs indicate genes predicted by
IPA to be bound (colored boxes) or not bound (white boxes) by each corresponding factor. Values are fold enrichment relative to
negative control (IgG), and error bars represent SEM based on three biological replicates each with three technical replicates for each
ChIP–qPCR reaction.
515Pluripotency and Genetic IntegrityDown-regulation of pluripotency factor gene
expression impacts expression of genetic
integrity genes
Finally, to further substantiate the existence of a mecha-
nistic link between the pluripotency and genetic integrity
networks, we mined data from a study published by Ivanova
et al. (2006) in which transcriptome databases were derived
from mouse ESCs following RNAi knockdowns of specific
pluripotency factors (SOX2, OCT4 or NANOG). We found that
approximately 13% of genetic integrity genes and 37% of
cell death genes predicted to be targeted by first-degree
interactions with these three pluripotency factors showed
altered expression levels following knockdown of one or more
pluripotency factor genes (Supplementary Table 6). Important-
ly, these knockdowns were each performed singly, and it is
possible that many of those genetic integrity genes we suggest
are targeted by first-degree interactions may be regulated by
more than one factor such that there is functional redundancy
in this regulatory process that might preclude down-regulation
in response to a knockdown of a single factor.
Discussion
The validity of the Disposable Soma Theory (Kirkwood, 1977) is
now well established for germ cells based on multiple
demonstrations that these cells maintain enhanced genetic
integrity relative to somatic cell types (Ehling and Neuhäuser,
1979; Russell et al., 1979; Walter et al., 1998), and that this is
accomplished thru up-regulation and/or differential expression
of genes in multiple DNA repair and cell death pathways (Chen
et al., 1995; Intano et al., 2001, 2002; Tichy and Stambrook,
2008). Thus, it appears that enhanced maintenance of geneticintegrity is a fundamental characteristic of germ cells (Murphey
et al., 2013). Previous studies have also revealed enhanced
maintenance of genetic integrity in pluripotent cells with
particular regard to point mutations (Hong et al., 2007;
Maynard et al., 2008; Momcilović et al., 2009; Van Sloun et
al., 1999) and have linked this to elevated DNA repair
(Hyka-Nouspikel et al., 2012) and cell death (Li et al., 2012;
Momcilović et al., 2011; Qin et al., 2007; Roos et al., 2007)
activities. Here we report data indicating that up (for DNA
repair) or differential (for cell death) regulation of genes
involved in maintenance of genetic integrity occurs in
pluripotent cells relative to differentiated cells (fibroblasts)
in a manner similar to that seen in germ cells and somatic cells,
respectively, indicating that enhanced maintenance of genetic
integrity is also a fundamental characteristic of pluripotent
cells. To better understand the mechanism by which enhanced
maintenance of genetic integrity is coordinately regulatedwith
pluripotency, we investigated interactions between the gene
networks that regulate each of these phenomena. Our results
reveal extensive interactions between these gene networks,
and suggest a mechanism by which induction and/or mainte-
nance of pluripotency directly leads to induction and/or
maintenance of enhanced genetic integrity.
Our meta-analysis of available transcriptome datasets
confirmed that expression of genes encoding proteins
involved in many, but not all DNA repair pathways is
elevated in pluripotent cells, suggesting that pluripotent
cells possess enhanced protection against a wide variety of
different types of DNA damage. Nucleotide excision repair
was the one DNA repair pathway that did not appear to be
up-regulated at the genomic level in pluripotent cells,
however this may be compensated by changes in activities
of cell death pathways (see below). We also found a distinct
up-regulation of intrinsically regulated, pro-apoptotic genes
516 D.J. Cooper et al.in pluripotent cells, suggesting these cells are predisposed to
respond to intrinsic triggers of programmed cell death. Such
triggers could come from a build-up of large-scale genetic
abnormalities such as polyploidy or aneuploidy (Eggan et al.,
2002), or from certain types of DNA damage such as that
caused by ionizing radiation (Momcilović et al., 2009; Van
Sloun et al., 1999; Xu et al., 2005, 2008). Indeed, it may be
that the lack of up-regulation of NER DNA repair genes in
pluripotent cells facilitates preferential elimination by
apoptosis of cells bearing large-scale damage or helix
distorting damage. NER is the major repair pathway for
ameliorating helix distorting lesions, such as photoproducts
(Bradley et al., 1984; Kuper and Kisker, 2012; Murphey et
al., 2009; Naegeli and Sugasawa, 2011; Thomson, 1998),
suggesting that helix distorting lesions in DNA may signal a
cell death response in pluripotent cells.
Taken together, these results suggest that two alterna-
tive strategies are employed by pluripotent cells to
minimize accumulation of genetic defects. Elevated ex-
pression of genes associated with intrinsically regulated
pro-apoptotic pathways in pluripotent cells appears to
promote a retrospective elimination of cells that accumu-
late large-scale genetic defects, whereas elevated activity
of most DNA repair pathways appears to facilitate a
prospective prevention of small-scale genetic defects such
as point mutations (which would normally not trigger cell
death pathways unless present in abundance). Together
these mechanisms appear to yield a population of pluripo-
tent cells that displays an overall enhanced level of genetic
and genomic integrity.
We next sought insight regarding the mechanism that links
regulation of pluripotency with that of enhanced maintenance
of genetic integrity in pluripotent cells. The discovery that fully
pluripotent cells can be derived by transduction of differenti-
ated cells starting with four (Takahashi and Yamanaka, 2006),
or fewer (Huangfu et al., 2008; Kim et al., 2009), key regulatory
genes suggests that small numbers of factors control entire
networks of downstream genes and gene products necessary to
establish the fate of a cell. We tested the hypothesis that small
numbers of pluripotency factors interact with large numbers of
genetic integrity genes in pluripotent cells. We found evidence
for extensive interactions between the pluripotency and
genetic integrity gene networks. While further research will
be needed to fully interrogate the functionality of each of the
molecular interactions predicted by our analysis, the predicted
interactions we report can account for the potential regulation
of 22–50% of DNA repair gene and 21–35% of cell death gene
differential expression in pluripotent cells. Undoubtedly, the
extent of interactions between these two gene networks would
be even greater if additional pluripotency factors and/or higher
order interactions were considered. Indeed, the involvement of
intermediary regulators linking the pluripotency and genetic
integrity gene networks affords potential opportunities for
additional levels of coordination of expression of downstream
genetic integrity pathways.Conclusions
In summary, our data indicate the Disposable Soma Theory
(Kirkwood, 1977) applies to pluripotent cells as well as to germ
cells. Further, we provide insight into themechanism bywhichthe pluripotency gene network interacts with the genetic
integrity gene network to establish and maintain enhanced
genetic integrity in pluripotent cells. This, in turn, suggests
that key factors might be monitored and/or manipulated to
maintain optimal genetic integrity in stem cells or their
differentiated derivatives intended for use in therapeutic
applications.
Supplementary data to this article can be found online at
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